Rocket Pharmaceuticals (RCKT) Capital Expenditures (2015 - 2026)
Rocket Pharmaceuticals (RCKT) posted Capital Expenditures of $93000.0 for Q1 2026, up 16.25% sequentially from $80000.0 in Q4 2025, and up 82.35% YoY from $51000.0 in Q1 2025.
Rocket Pharmaceuticals (RCKT) Capital Expenditures (2015 - 2026) Analysis & Trends
Rocket Pharmaceuticals has reported Capital Expenditures for 12 years, with the latest figure at $93000.0 in Q1 2026.
- Quarterly Capital Expenditures rose 82.35% year-over-year to $93000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $482000.0 (down 87.57% YoY) and the FY2025 annual result came in at $440000.0, down 92.49% from the prior year.
- Capital Expenditures rose to $93000.0 in Q1 2026 per RCKT's latest filing, from $80000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $14.8 million in Q4 2023 and troughed at -$3.7 million in Q3 2024.
- A 5-year average of $1.5 million and a median of $405000.0 in 2023 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures surged 552.94% in 2023, then plunged 1013.58% in 2024.
- Over 5 years, Capital Expenditures stood at -$3.3 million in 2022, then soared by 552.94% to $14.8 million in 2023, then slumped by 62.1% to $5.6 million in 2024, then slumped by 98.57% to $80000.0 in 2025, then advanced by 16.25% to $93000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $93000.0, $80000.0, and $360000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Rocket Pharmaceuticals | 380.92 Mn | 380.92 Mn | - | 8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8,000.00 |
| Jun 30, 2026 | 8,000.00 |
| Mar 31, 2026 | 93,000.00 |
| Mar 31, 2026 | 93,000.00 |
| Dec 31, 2025 | 80,000.00 |
| Dec 31, 2025 | 80,000.00 |
| Sep 30, 2025 | 360,000.00 |
| Sep 30, 2025 | 360,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 5.60 Mn |
| Dec 31, 2024 | 5.60 Mn |
| Sep 30, 2024 | -3.70 Mn |
| Sep 30, 2024 | -3.70 Mn |
| Jun 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | 1.93 Mn |
| Mar 31, 2024 | 2.04 Mn |
| Mar 31, 2024 | 2.04 Mn |